Artificial Vital Organs and Medical Bionics Market - Size, Share, Outlook, and Opportunity Analysis, 2019

Artificial Vital Organs are man-made devices that are created to work like original diseases organ or to restore a specific function of that organ. These devices are implanted at the site of the diseased organ in the patient. Medical bionics is the study of application of mechanics and electronics for the replacement of a limb or other part of a functional organ that is mechanically powered. Artificial organs can be an artificial heart, artificial kidney, artificial pancreas and others. An artificial organ consists of different parts that mimic functions of the original organ. For instance, artificial pancreas systems comprise of devices that are already used in diabetes management such as Continuous glucose monitoring (CGM) device, insulin pump, blood glucose device (BGD), and digital control device with control algorithm. Artificial pancreas systems are compatible with existing pumps and CGMs and its control functions can be integrated into a regular smartphone.

Restraints of the Global Artificial Vital Organs and Medical Bionics Market

Major factors hampering the growth of the Artificial Vital Organs and Medical Bionics market during the forecast period constitutes of criticism associated with artificial organ transplant, and high costs.

Key features of the study:

This report provides in-depth analysis of the global Artificial Vital Organs and Medical Bionics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Artificial Vital Organs and Medical Bionics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Artificial Vital Organs and Medical Bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Artificial Vital Organs and Medical Bionics Market, By Type: